Old Web
English
Sign In
Acemap
>
Paper
>
P59.25 Prognostic and Treatment Characteristics of Metastatic KRAS G12C Mutant NSCLC
P59.25 Prognostic and Treatment Characteristics of Metastatic KRAS G12C Mutant NSCLC
2021
A. Elegbede
Doreen A. Ezeife
A. Gibson
Michelle Dean
L. Petersen
Gwyn Bebb
Keywords:
Cancer research
Mutant
KRAS
treatment characteristics
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]